Cargando…

Vitamin D and Cathelicidin (LL-37) Status in Patients with Type 2 Diabetes and Staphylococcus aureus Nasal Carriage

OBJECTIVE: Type 2 diabetes mellitus (T2D) is characterized by the dysregulation of innate immunity leading to higher rates of Staphylococcus aureus nasal carriage, an important risk factor for severe infections. 25-hydroxy vitamin D (25(OH) D) may contribute, via the production of the antimicrobial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plataki, Marina N., Vamvoukaki, Rodanthi, Samonis, George, Bikis, Charalampos, Gorgomiti, Maria, Papadakis, John A., Maraki, Sofia, Kofteridis, Diamantis P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SBDR - Society for Biomedical Diabetes Research 2021
Materias:	Original Data
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380094/ https://www.ncbi.nlm.nih.gov/pubmed/34289005 http://dx.doi.org/10.1900/RDS.2021.17.30

Ejemplares similares

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
por: Tokajuk, Joanna, et al.
Publicado: (2022)

A Retrospective Study of Staphylococcus aureus Bacteremia in a Tertiary Hospital and Factors Associated with Mortality
por: Ioannou, Petros, et al.
Publicado: (2023)

Pulmonary defense and the human cathelicidin hCAP-18/LL-37
por: Fahy, R. J., et al.
Publicado: (2005)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
por: Simonetti, Oriana, et al.
Publicado: (2021)

Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
por: Reinholz, Markus, et al.
Publicado: (2012)

Transformation of Human Cathelicidin LL-37 into Selective, Stable, and Potent Antimicrobial Compounds
por: Wang, Guangshun, et al.
Publicado: (2014)

Upregulation of human β-defensin-3 and cathelicidin LL-37 in Kaposi’s sarcoma
por: Fathy, Hanan, et al.
Publicado: (2012)

The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs
por: Kuroda, Kengo, et al.
Publicado: (2015)

Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans
por: Guo, Yi-jie, et al.
Publicado: (2016)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
por: Babikir, Ibrahim H., et al.
Publicado: (2018)

Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health
por: Khurshid, Zohaib, et al.
Publicado: (2017)

Cathelicidin LL37 Promotes Osteogenic Differentiation in vitro and Bone Regeneration in vivo
por: Li, Lunhao, et al.
Publicado: (2021)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
por: Kang, Jason, et al.
Publicado: (2019)

The Human Nasal Microbiota and Staphylococcus aureus Carriage
por: Frank, Daniel N., et al.
Publicado: (2010)

Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
por: Niemirowicz, Katarzyna, et al.
Publicado: (2016)

The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
por: Currie, Silke M., et al.
Publicado: (2013)

Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
por: Majewski, Karol, et al.
Publicado: (2018)

Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia
por: Podaza, Enrique, et al.
Publicado: (2020)

Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus
por: Moreno-Angarita, Alejandro, et al.
Publicado: (2019)

A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital
por: Maraki, Sofia, et al.
Publicado: (2016)

Role of Nasal Carriage of Staphylococcus aureus in Chronic Urticaria
por: Sharma, Ashimav Deb
Publicado: (2012)

On the evolution of virulence during Staphylococcus aureus nasal carriage
por: Young, Bernadette C., et al.
Publicado: (2012)

Oropharyngeal and nasal Staphylococcus aureus carriage by healthy children
por: Esposito, Susanna, et al.
Publicado: (2014)

The Dynamic of Staphylococcus aureus Nasal Carriage in Central Iran
por: Fard-Mousavi, Nasimeh, et al.
Publicado: (2015)

Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages
por: Li, Hsin-Ni, et al.
Publicado: (2009)

The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis
por: Zhang, Ying, et al.
Publicado: (2013)

The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds
por: Duplantier, Allen J., et al.
Publicado: (2013)

Heparan Sulfate Proteoglycan–Involving Immunomodulation by Cathelicidin Antimicrobial Peptides LL-37 and PR-39
por: Kaneider, Nicole C., et al.
Publicado: (2007)

Cathelicidin LL-37 restoring glucocorticoid function in smoking and lipopolysaccharide-induced airway inflammation in rats
por: Weng, Jian-Zhen, et al.
Publicado: (2019)

Cathelicidins PMAP-36, LL-37 and CATH-2 are similar peptides with different modes of action
por: Scheenstra, Maaike R., et al.
Publicado: (2019)

Retraction Note: Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans
por: Guo, Yi-jie, et al.
Publicado: (2017)

Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13
por: Niemirowicz, Katarzyna, et al.
Publicado: (2017)

Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model
por: Nagaoka, Isao, et al.
Publicado: (2020)

Citrullination Alters the Antiviral and Immunomodulatory Activities of the Human Cathelicidin LL-37 During Rhinovirus Infection
por: Casanova, Víctor, et al.
Publicado: (2020)

Sequence determinants in the cathelicidin LL-37 that promote inflammation via presentation of RNA to scavenger receptors
por: Kulkarni, Nikhil N., et al.
Publicado: (2021)

Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37
por: Krishnamoorthy, Rajavenkatesh, et al.
Publicado: (2023)

Evaluation of antimicrobial peptide LL-37 for treatment of Staphylococcus aureus biofilm on titanium plate
por: Wei, Jiantong, et al.
Publicado: (2021)

Staphylococcus aureus nasal carriage in hemodialysis centers of Fez, Morocco
por: Diawara, Idrissa, et al.
Publicado: (2014)

Determinants of Staphylococcus aureus carriage in the developing infant nasal microbiome
por: Accorsi, Emma K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_votkq23qmkb48ac9rjkm6tce6q